{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:24:37Z","timestamp":1787156677175,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2023-148753OB-100"],"award-info":[{"award-number":["PID2023-148753OB-100"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["FPU21\/02736"],"award-info":[{"award-number":["FPU21\/02736"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpain.2026.106329","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:36:34Z","timestamp":1779899794000},"page":"106329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["New strategy for treating visceral pain: Enhancing opioid antinociception by Sigma-1 receptor inhibition"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5495-9389","authenticated-orcid":false,"given":"Antonia","family":"Artacho-Cord\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2842-0085","authenticated-orcid":false,"given":"Miguel \u00c1.","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4585-3715","authenticated-orcid":false,"given":"Enrique","family":"Portillo-Salido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5757-9066","authenticated-orcid":false,"given":"Carolina","family":"Roza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cruz Miguel","family":"Cend\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpain.2026.106329_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/j.pain.0000000000001362","article-title":"The IASP classification of chronic pain for ICD-11: chronic secondary visceral pain","volume":"160","author":"Aziz","year":"2019","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpain.2026.106329_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: The IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"issue":"10263","key":"10.1016\/j.jpain.2026.106329_bib3","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(20)31548-8","article-title":"Irritable bowel syndrome","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jpain.2026.106329_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/mi.8.5.9","article-title":"Inside information: the unique features of visceral sensation","volume":"8","author":"Robinson","year":"2008","journal-title":"Mol Interv"},{"issue":"Suppl. 1","key":"10.1016\/j.jpain.2026.106329_bib5","first-page":"3","article-title":"Visceral versus somatic pain: similarities and differences","volume":"27","author":"Cervero","year":"2010"},{"key":"10.1016\/j.jpain.2026.106329_bib6","article-title":"Drug management of visceral pain: concepts from basic research","volume":"2012","author":"Davis","year":"2012","journal-title":"Pain Res Treat"},{"issue":"1","key":"10.1016\/j.jpain.2026.106329_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2982.2006.00873.x","article-title":"Peripheral and central mechanisms of visceral sensitization in man","volume":"19","author":"Anand","year":"2007","journal-title":"Neurogastroenterol Motil"},{"issue":"9170","key":"10.1016\/j.jpain.2026.106329_bib8","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(99)01306-9","article-title":"Visceral pain","volume":"353","author":"Cervero","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jpain.2026.106329_bib9","series-title":"The Oxford Handbook of the Neurobiology of Pain","first-page":"470","article-title":"Visceral pain","author":"Bulmer","year":"2018"},{"issue":"2","key":"10.1016\/j.jpain.2026.106329_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/eujp.1999.0117","article-title":"Recent and forgotten aspects of visceral pain","volume":"3","author":"Giamberardino","year":"1999","journal-title":"Eur J Pain"},{"issue":"6","key":"10.1016\/j.jpain.2026.106329_bib11","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2024.01.045","article-title":"Chronic visceral pain: new peripheral mechanistic insights and resulting treatments","volume":"166","author":"Ford","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jpain.2026.106329_bib12","first-page":"1","article-title":"Prevalence of opioid use and associated healthcare outcomes in Rome IV irritable bowel syndrome in the United Kingdom","volume":"0","author":"Butt","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jpain.2026.106329_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jnr.24695","article-title":"Pain management with opioids in adults","volume":"100","author":"Montgomery","year":"2022","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1016\/j.jpain.2026.106329_bib14","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"issue":"2","key":"10.1016\/j.jpain.2026.106329_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1017\/S0265021507001226","article-title":"Gabapentin action and interaction on the antinociceptive effect of morphine on visceral pain in mice","volume":"25","author":"Meymandi","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jpain.2026.106329_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114649","article-title":"Benzylaminofentanyl derivates: discovery of bifunctional \u03bc opioid and \u03c31 receptor ligands as novel analgesics with reduced adverse effects","volume":"241","author":"Zhuang","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"16","key":"10.1016\/j.jpain.2026.106329_bib17","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.3390\/jcm10163533","article-title":"Combination therapy for neuropathic pain: a review of recent evidence","volume":"10","author":"Afonso","year":"2021","journal-title":"J Clin Med"},{"issue":"24","key":"10.1016\/j.jpain.2026.106329_bib18","doi-asserted-by":"crossref","first-page":"15508","DOI":"10.1021\/acs.jmedchem.0c01127","article-title":"Discovery of EST73502, a dual \u03bc-opioid receptor agonist and \u03c31 receptor antagonist clinical candidate for the treatment of pain","volume":"63","author":"Garc\u00eda","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpain.2026.106329_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105339","article-title":"Sigma-1 receptor: a drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain","volume":"163","author":"Ruiz-Cantero","year":"2021","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.jpain.2026.106329_bib20","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jpain.2026.106329_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-3-319-50174-1_8","article-title":"Pharmacological modulation of the sigma 1 receptor and the treatment of pain","volume":"964","author":"Merlos","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jpain.2026.106329_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-319-50174-1_9","article-title":"Sigma-1 receptor antagonists: a new class of neuromodulatory analgesics","volume":"964","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.jpain.2026.106329_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/mol.109.057083","article-title":"Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding","volume":"77","author":"Kim","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.jpain.2026.106329_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.113.208272","article-title":"Modulation of peripheral \u03bc-opioid analgesia by \u03c31 receptors","volume":"348","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2026.106329_bib25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neuropharm.2013.03.002","article-title":"Potentiation of morphine-induced mechanical antinociception by \u03c31 receptor inhibition: role of peripheral \u03c31 receptors","volume":"70","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2013","journal-title":"Neuropharmacology"},{"issue":"JUN","key":"10.1016\/j.jpain.2026.106329_bib26","article-title":"Ligands exert biased activity to regulate sigma 1 receptor interactions with cationic TRPA1, TRPV1, and TRPM8 channels","volume":"10","author":"Cort\u00e9s-Montero","year":"2019","journal-title":"Front Pharmacol"},{"issue":"31","key":"10.1016\/j.jpain.2026.106329_bib27","doi-asserted-by":"crossref","first-page":"8396","DOI":"10.1073\/pnas.1620068114","article-title":"Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice","volume":"114","author":"Tejada","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jpain.2026.106329_bib28","article-title":"The role of neutrophils in pain: systematic review and meta-analysis of animal studies","author":"Huerta","year":"2024","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.jpain.2026.106329_bib29","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/bph.16003","article-title":"The sigma-1 receptor curtails endogenous opioid analgesia during sensitization of TRPV1 nociceptors","volume":"180","author":"Ruiz-Cantero","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2026.106329_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123953","article-title":"Generation and phenotypic characterization of a sigma-1 receptor knockout rat","author":"Huerta","year":"2025","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.jpain.2026.106329_bib31","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pain.2009.05.013","article-title":"Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury","volume":"145","author":"Puente","year":"2009","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.jpain.2026.106329_bib32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/FBP.0000000000000038","article-title":"S1RA, a selective sigma-1 receptor antagonist, inhibits inflammatory pain in the carrageenan and complete Freund\u2019s adjuvant models in mice","volume":"25","author":"Gris","year":"2014","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.jpain.2026.106329_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/164_2017_9","article-title":"Sigma-1 receptor and pain","volume":"244","author":"Merlos","year":"2017","journal-title":"Handb Exp Pharmacol"},{"issue":"1-3","key":"10.1016\/j.jpain.2026.106329_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2013.04.018","article-title":"Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects","volume":"711","author":"Vidal-Torres","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"10.1016\/j.jpain.2026.106329_bib35","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1021\/acs.jmedchem.1c00417","article-title":"Propionamide derivatives as dual \u03bc-opioid receptor agonists and \u03c31receptor antagonists for the treatment of pain","volume":"64","author":"Garc\u00eda","year":"2021","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.jpain.2026.106329_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(95)11504-P","article-title":"Sigma antagonists potentiate opioid analgesia in rats","volume":"190","author":"Chien","year":"1995","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.jpain.2026.106329_bib37","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/jpet.107.121137","article-title":"Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study","volume":"322","author":"Mei","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpain.2026.106329_bib38","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1124\/jpet.300.3.1070","article-title":"\u03c21 Receptor modulation of opioid analgesia in the mouse","volume":"300","author":"MEI","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.jpain.2026.106329_bib39","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/ALN.0b013e318280a60a","article-title":"\u03c31Receptors are involved in the visceral pain induced by intracolonic administration of capsaicin in mice","volume":"118","author":"Gonz\u00e1lez-Cano","year":"2013","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1016\/j.jpain.2026.106329_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102758","article-title":"Genetic and pharmacological blockade of sigma-1 receptors attenuates inflammation-associated hypersensitivity during acute colitis in CD1 mice","volume":"11","author":"L\u00f3pez-Est\u00e9vez","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpain.2026.106329_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104724","article-title":"Urinary bladder sigma-1 receptors: a new target for cystitis treatment","volume":"155","author":"Gonz\u00e1lez-Cano","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jpain.2026.106329_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115534","article-title":"Sigma-1 receptor agonism exacerbates immune-driven nociception: Role of TRPV1 + nociceptors","volume":"167","author":"Ruiz-Cantero","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.jpain.2026.106329_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pain.2009.03.011","article-title":"Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice","volume":"143","author":"Entrena","year":"2009","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpain.2026.106329_bib44","doi-asserted-by":"crossref","DOI":"10.1007\/s11481-024-10144-8","article-title":"Sigma-1 receptors control neuropathic pain and peripheral neuroinflammation after nerve injury in female mice: a transcriptomic study","volume":"19","author":"Ruiz-Cantero","year":"2024","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"10.1016\/j.jpain.2026.106329_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jpain.2026.106329_bib46","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma 1 receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"10.1016\/j.jpain.2026.106329_bib47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(95)00208-3","article-title":"Characterization of two novel \u03c3 receptor ligands: antidystonic effects in rats suggest \u03c3 receptor antagonism","volume":"280","author":"Matsumoto","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.jpain.2026.106329_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0304-3959(01)00275-5","article-title":"A new model of visceral pain and referred hyperalgesia in the mouse","volume":"92","author":"Laird","year":"2001","journal-title":"Pain"},{"issue":"MAY","key":"10.1016\/j.jpain.2026.106329_bib49","article-title":"Up-down reader: an open source program for efficiently processing 50% von frey thresholds","volume":"9","author":"Gonzalez-Cano","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpain.2026.106329_bib50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.jpain.2026.106329_bib51","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s43440-025-00727-4","article-title":"Involvement of TRPV1 and MOR-NMDAR complex on the antiallodynic effect of LMH-2, a sigma-1 receptor antagonist, in mouse model of diabetic neuropathy - a behavioral approach","volume":"77","author":"Ventura-Mart\u00ednez","year":"2025","journal-title":"Pharmacol Rep"},{"issue":"7","key":"10.1016\/j.jpain.2026.106329_bib52","doi-asserted-by":"crossref","first-page":"E1657","DOI":"10.1073\/pnas.1715972115","article-title":"TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain","volume":"115","author":"Ort\u00edz-Renter\u00eda","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.jpain.2026.106329_bib53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/md15060188","article-title":"Effects of tetrodotoxin in mouse models of visceral pain","volume":"15","author":"Gonz\u00e1lez-Cano","year":"2017","journal-title":"Mar Drugs"},{"key":"10.1016\/j.jpain.2026.106329_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107537","article-title":"The proof of concept of 2-{3-[N-(1-benzylpiperidin-4-yl)propyl]amino}-6-[N-methyl-N-(prop-2-yn-1-yl)amino]-4-phenylpyridine-3,5-dicarbonitrile for the therapy of neuropathic pain","volume":"150","author":"Entrena","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.jpain.2026.106329_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117037","article-title":"Development of selective sigma-1 receptor ligands with antiallodynic activity: a focus on piperidine and piperazine scaffolds","volume":"281","author":"Cosentino","year":"2025","journal-title":"Eur J Med Chem"},{"issue":"7","key":"10.1016\/j.jpain.2026.106329_bib56","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1021\/acs.jmedchem.2c02081","article-title":"Conformationally restricted \u03c31 receptor antagonists from (\u2212)-isopulegol","volume":"66","author":"Blicker","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpain.2026.106329_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114113","article-title":"Synthesis of tropane-based \u03c31 receptor antagonists with antiallodynic activity","volume":"230","author":"Bechthold","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"23","key":"10.1016\/j.jpain.2026.106329_bib58","doi-asserted-by":"crossref","first-page":"14979","DOI":"10.1021\/acs.jmedchem.0c01575","article-title":"EST64454: a highly soluble \u03c31receptor antagonist clinical candidate for pain management","volume":"63","author":"D\u00edaz","year":"2020","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.jpain.2026.106329_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-020-00676-4","article-title":"The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception","volume":"13","author":"S\u00e1nchez-Bl\u00e1zquez","year":"2020","journal-title":"Mol Brain"},{"issue":"3","key":"10.1016\/j.jpain.2026.106329_bib60","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0022-3565(25)24045-9","article-title":"Selective antagonism of opioid analgesia by a sigma system","volume":"271","author":"Chien","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"FEB","key":"10.1016\/j.jpain.2026.106329_bib61","article-title":"Modulation by sigma-1 receptor of morphine analgesia and tolerance: nociceptive pain, tactile allodynia and grip strength deficits during joint inflammation","volume":"10","author":"Montilla-Garc\u00eda","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpain.2026.106329_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118298","article-title":"Sigma-1 receptor antagonism as a promising strategy for postoperative pain treatment: a study in laparotomized mice","volume":"189","author":"Santos-Caballero","year":"2025","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.jpain.2026.106329_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/ejp.4755","article-title":"E-52862-A selective sigma-1 receptor antagonist, in peripheral neuropathic pain: Two randomized, double-blind, phase 2 studies in patients with chronic postsurgical pain and painful diabetic neuropathy","volume":"29","author":"G\u00e1lvez","year":"2025","journal-title":"Eur J Pain"},{"issue":"1","key":"10.1016\/j.jpain.2026.106329_bib64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s13311-017-0572-5","article-title":"Efficacy of a novel sigma-1 receptor antagonist for oxaliplatin-induced neuropathy: a randomized, double-blind, placebo-controlled Phase II a clinical trial","volume":"15","author":"Bruna","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.jpain.2026.106329_bib65","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2125.2012.04333.x","article-title":"Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma-1 receptor antagonist in three randomized phase I studies","volume":"75","author":"Abadias","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.jpain.2026.106329_bib66","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/13543784.2015.1048334","article-title":"Investigational sigma-1 receptor antagonists for the treatment of pain","volume":"24","author":"Vela","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jpain.2026.106329_bib67","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuropharm.2015.11.024","article-title":"Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice","volume":"102","author":"Bagdas","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2-3","key":"10.1016\/j.jpain.2026.106329_bib68","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainresbull.2011.10.018","article-title":"The central versus peripheral antinociceptive effects of \u03bc-opioid receptor agonists in the new model of rat visceral pain","volume":"87","author":"Al-Khrasani","year":"2012","journal-title":"Brain Res Bull"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590026001471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590026001471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:29:19Z","timestamp":1787153359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590026001471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":68,"alternative-id":["S1526590026001471"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2026.106329","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New strategy for treating visceral pain: Enhancing opioid antinociception by Sigma-1 receptor inhibition","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2026.106329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 \u00a9 Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106329"}}